TerrAscend (TSNDF) Other Operating Expenses (2021 - 2026)
TerrAscend's (TSNDF) quarterly Other Operating Expenses came in at -$36000.0 in Q1 2026, down 102.79% year-on-year from $1.3 million in Q1 2025, and down 100.89% on a QoQ basis from $4.0 million in Q4 2025.
TerrAscend (TSNDF) Other Operating Expenses (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Other Operating Expenses data on file, last reported at -$36000.0 in Q1 2026.
- On a quarterly basis, Other Operating Expenses fell 102.79% year-over-year to -$36000.0 in Q1 2026; TTM through Mar 2026 was $6.7 million, a 172.68% increase from a year earlier, with the FY2025 full-year figure at -$33000.0, down 102.77% from the prior year.
- Other Operating Expenses for Q1 2026 stood at -$36000.0, down from $4.0 million in the prior quarter.
- Over the last five years, Other Operating Expenses for TSNDF reached as high as $4.7 million in Q1 2024 and fell as low as -$16.8 million in Q4 2022.
- Historically, Other Operating Expenses has averaged $143058.8 across 5 years, with a median of $1.2 million in 2024.
- Across the five-year window, Other Operating Expenses sank 9363.54% in 2022 and jumped 19104.76% in 2025, its largest moves.
- Year by year, Other Operating Expenses stood at -$16.8 million in 2022, then jumped by 98.17% to -$307000.0 in 2023, then soared by 106.84% to $21000.0 in 2024, then soared by 19104.76% to $4.0 million in 2025, then plunged by 100.89% to -$36000.0 in 2026.
- Per Business Quant data, the three most recent Other Operating Expenses figures were -$36000.0 in Q1 2026, $4.0 million in Q4 2025, and $1.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36,000.00 |
| Dec 31, 2025 | 4.03 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 1.28 Mn |
| Mar 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | 21,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 4.65 Mn |
| Dec 31, 2023 | -307,000.00 |
| Sep 30, 2023 | 1.88 Mn |
| Jun 30, 2023 | -10,000.00 |
| Mar 31, 2023 | 2.36 Mn |
| Dec 31, 2022 | -16.77 Mn |
| Sep 30, 2022 | 81,000.00 |
| Jun 30, 2022 | -845,000.00 |
| Mar 31, 2022 | 2.18 Mn |
| Dec 31, 2021 | 181,000.00 |
| Sep 30, 2021 | -219,000.00 |
| Jun 30, 2021 | -37,000.00 |